Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	56.13	69.8	57.42	68.18	126.91	31.3
Short-Term Investments	-	-	-	-	0.77	0.75
Cash & Short-Term Investments	56.13	69.8	57.42	68.18	127.68	32.04
Cash Growth	-35.81%	21.56%	-15.78%	-46.60%	298.48%	48.00%
Other Receivables	2.75	2.79	3.13	2.31	2.46	5.78
Receivables	2.75	2.79	3.13	2.31	2.46	5.78
Prepaid Expenses	2.55	0.33	0.97	3.78	3.79	2.21
Other Current Assets	-	1.85	2.23	0.92	0.55	0.56
Total Current Assets	61.42	74.76	63.76	75.2	134.49	40.58
Property, Plant & Equipment	0.74	0.98	1.65	2.22	3.43	2.15
Other Intangible Assets	0.47	0.64	1.09	-	33.26	43.21
Total Assets	62.63	76.39	66.5	77.41	171.18	85.94
Accounts Payable	1.14	2.68	2.35	3.49	3.09	4.32
Accrued Expenses	5.04	4.57	5.75	5.64	5.44	5.9
Current Portion of Long-Term Debt	-	5.54	-	13.33	-	-
Current Portion of Leases	0.6	0.71	0.65	0.56	0.84	0.87
Current Income Taxes Payable	-	-	-	-	2.06	-
Other Current Liabilities	0.78	0.36	0.74	1.36	5.55	0.6
Total Current Liabilities	7.56	13.85	9.49	24.38	16.98	11.69
Long-Term Debt	-	-	4.39	-	19.48	22.04
Long-Term Leases	-	0.19	0.91	1.48	2.38	1.58
Other Long-Term Liabilities	0.9	1.39	1.18	0.16	13.18	71.07
Total Liabilities	8.45	15.42	15.96	26.01	52.02	106.38
Common Stock	3.13	3.06	2.78	2.48	2.38	1.39
Additional Paid-In Capital	546.33	539.64	486.11	476.52	335.08	220.88
Retained Earnings	-486.64	-462.88	-419.63	-404.58	-402.11	-422.82
Treasury Stock	-	-	-1.23	-1.34	-	-
Comprehensive Income & Other	-8.64	-18.85	-17.49	-21.69	183.82	180.11
Shareholders' Equity	54.18	60.97	50.54	51.4	119.16	-20.44
Total Liabilities & Equity	62.63	76.39	66.5	77.41	171.18	85.94
Total Debt	0.6	6.43	5.95	15.37	22.69	24.49
Net Cash (Debt)	55.52	63.37	51.47	52.81	104.99	7.55
Net Cash Growth	-31.68%	23.13%	-2.54%	-49.70%	1289.80%	-
Net Cash Per Share	0.35	0.43	0.39	0.44	0.95	0.11
Filing Date Shares Outstanding	159.1	159	140.01	124.74	116.73	108
Total Common Shares Outstanding	159	155.15	140	124.74	116.73	67.54
Working Capital	53.86	60.92	54.27	50.82	117.51	28.89
Book Value Per Share	0.34	0.39	0.36	0.41	1.02	-0.30
Tangible Book Value	53.71	60.33	49.45	51.4	85.9	-63.65
Tangible Book Value Per Share	0.34	0.39	0.35	0.41	0.74	-0.94
Machinery	-	0.49	0.5	0.61	0.48	0.28
Leasehold Improvements	-	0.71	0.71	0.68	0.75	0.22

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q